BioSpace News Archive

Debiotech will be collaborating with vaccine companies, foundations and public organizations, using its unique DebioJect™ Microneedle, to improve the effectiveness of COVID-19 vaccines by reducing the necessary dose to achieve a sufficient immune response.

Two world class safety organizations – ORC HSE Strategies, LLC and National Safety Council along with its Campbell Institute – announced a joint agreement to assist workplaces in responding to COVID-19 safety-related issues.

RxMx, a global healthcare technology company that provides digital patient management, safety and adherence solutions to pharmaceutical manufacturers, is pleased to announce Covid Clear.

HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine (ChAdOx1 nCoV-19), being developed by the University’s Jenner Institute. This GMP manufacturing scale-up is taking place alongside early phase clinical trials.

ADOCIA (Euronext Paris: FR0011184241 – ADOC the “Company”and “Adocia”), a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced today its financial results, including revenue and cash position, for the quarter ended March 31st, 2020.

InVivo Therapeutics Holdings Corp. (NVIV) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,715,240 shares of its common stock at a purchase price of $1.75 per share

New reports and surveillance tools from LSI are forecasting the impact of the Coronavirus pandemic on surgical procedures across elective and non-elective categories. HUNTINGTON BEACH, Calif.--( BUSINESS WIRE )-- Leading medtech market research firm Life Science Intelligence (LSI) has been tracking surgical procedure volumes across 37 countries for the last decade. The firm is seeing massive shifts in volumes occurring as a result of the Coronav

Ascent®, one of America’s fastest-growing sports nutrition companies, just announced it is supporting those impacted by COVID-19 through the creation of the Gym Relief Fund and contributions to other initiatives.

Assistek , a leader in delivering eSource solutions to collect data, electronically, from patients and clinicians in clinical trials t oday announced the release of its novel web-based electronic clinical outcome assessments (eCOA) solution to support remote data collection for patients and sites during these times of challenge d

Information on the progress of our subsidiary ViralClear Pharmaceuticals and Vicromax(tm) – a broad-spectrum orally administered anti-viral candidate for COVID-19 Upon receipt of FDA approval, Phase II clinical trial is planned to be conducted at Mayo Clinic and is set to commence within the next several weeks under the leadership of Andrew D. Badley, M.D., Chair of the COVID-19 Task Force Update on the PURE EP(tm) System comme